Insulin increases CSF Abeta42 levels in normal older adults.
about
Exercise programs for people with dementiaExercise interventions for preventing dementia or delaying cognitive decline in people with mild cognitive impairmentExercise interventions for maintaining cognitive function in cognitively healthy people in mid lifeExercise interventions for maintaining cognitive function in cognitively healthy people in late lifeBrain structure and obesityThe Rationale for Insulin Therapy in Alzheimer's DiseaseShared Neuropathological Characteristics of Obesity, Type 2 Diabetes and Alzheimer's Disease: Impacts on Cognitive DeclineType 2 diabetes and cognitive impairment: linking mechanismsInsulin in the brain: there and back againAlzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersInsulin: an emerging treatment for Alzheimer's disease dementia?Impact of postprandial glycaemia on health and prevention of diseaseTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseAberrant insulin signaling in Alzheimer's disease: current knowledgeAlzheimer's disease and type 2 diabetes via chronic inflammatory mechanismsBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease'Adipaging': ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue.Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Vascular risk factors: imaging and neuropathologic correlates.Aggregation of vascular risk factors and risk of incident Alzheimer disease.Presenilin-1 regulates induction of hypoxia inducible factor-1α: altered activation by a mutation associated with familial Alzheimer's diseaseType 3 diabetes is sporadic Alzheimer׳s disease: mini-review.Diabetes, insulin resistance, and dementia among HIV-1-infected patientsType 2 diabetes mellitus, dyslipidemia, and Alzheimer's diseaseGinsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.Effects of aerobic exercise on mild cognitive impairment: a controlled trialInsulin-resistant brain state: the culprit in sporadic Alzheimer's disease?Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin.A common pathogenic mechanism linking type-2 diabetes and Alzheimer's disease: evidence from animal models.The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study.Type 2 diabetes and late-onset Alzheimer's diseaseObesity is linked with lower brain volume in 700 AD and MCI patientsDoes diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease.Emerging therapeutics for Alzheimer's disease: an avenue of hope.MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trialMechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease.Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging.Cardiovascular risk factors and Alzheimer's disease.Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease
P2860
Q24186512-02CF4E6C-0171-43C2-9948-2443361821D1Q24188208-EE7AA104-7857-4537-951E-CD2A635424CCQ24188214-950AA62D-A225-4D62-92A7-F3482D912A2CQ24188220-71987C72-70E1-414D-A27A-640F46BF42D3Q24644378-C7107FC2-F9BF-4A9E-8FF2-67A0DE45DF5EQ26744834-55A87D3D-45E7-4437-A6D4-684B707E4B03Q26784170-A8F848EF-68C9-4943-B198-DE96519ADCC6Q26822993-2374968D-0A11-464F-B250-273E8333F01FQ26825385-4D7E45E7-B81D-48BB-BAC6-CE38D3763347Q26825442-65AE9603-24E3-4758-B380-A619AF25491FQ26827376-C8CE0278-CA65-4889-837D-88D7233D0E8BQ26862823-5A111099-828F-4AF7-9C00-BE25302DEDF9Q27021700-49A8683D-C6FB-4D22-8B9A-0A22220A83CFQ27024222-C25BFC09-9BDE-40F4-9802-C815B7CA48F1Q28086892-28A67EAF-F269-4EC6-9FE5-40BD15A47C1EQ28259585-0C82169D-5282-46BA-9361-626AA21EA4F7Q30385053-16749ABA-73E4-4B1B-86C6-2FC3445E65A1Q33628048-D00623CC-231E-4040-B7B3-0407283C9C65Q33905844-AB5FEC23-0F60-4243-A6D0-64FEBDB0DEFDQ33989502-46A1659A-E249-484C-BFE8-0B9E6289488AQ34203028-953669B2-900D-4F3E-A82C-E30ECF172AB6Q34432135-96DBDBBB-5954-439A-90FC-2FAFA8FCBAB2Q34483421-BF49A037-8F9B-4825-B845-BA541BF930FFQ34533985-CCE4DB46-D11A-4F30-B74C-C368BC8D22A0Q34632017-D8AFE6A8-39AD-4479-9944-C651899B00D1Q34666688-A721F334-C217-4074-92CF-FA0952C772ABQ34669518-8024C2AC-A16E-4FFF-8793-B98288AC7189Q34777829-09866FCB-373C-4A29-846F-EE24C1F89013Q34811570-EA1B10D5-630D-4249-94F3-5F97E4B793CBQ35033208-FE34D319-BABD-49B7-82E5-6B89E39EA435Q35123597-BF9B04D8-A37A-4F5D-9EB0-D023ED4E5194Q35401263-0E600256-78C2-45E9-9535-72EEACCB91E3Q35618911-4DA37BC7-3717-4840-BF52-9A69B51E2809Q35618922-93E58079-30CA-4D89-839A-C76AC3C49310Q35625246-28664E14-8DD8-4A33-A7E8-FD183ABC5D7FQ35679839-170FA4AE-EE3D-4EFD-B091-292D087074FBQ35687287-87C5C737-A0A1-4502-AB66-24EAB7E4429CQ35690851-A27A8CFB-1A0E-400B-B858-F83C03C6B1DFQ35801866-94401B88-8158-481C-A8AE-C08E54918CABQ35997824-F800DA2D-FC9E-437D-A398-2403E94F3333
P2860
Insulin increases CSF Abeta42 levels in normal older adults.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Insulin increases CSF Abeta42 levels in normal older adults.
@en
Insulin increases CSF Abeta42 levels in normal older adults.
@nl
type
label
Insulin increases CSF Abeta42 levels in normal older adults.
@en
Insulin increases CSF Abeta42 levels in normal older adults.
@nl
prefLabel
Insulin increases CSF Abeta42 levels in normal older adults.
@en
Insulin increases CSF Abeta42 levels in normal older adults.
@nl
P2093
P1433
P1476
Insulin increases CSF Abeta42 levels in normal older adults.
@en
P2093
Peskind ER
Purganan K
Schwartz MW
P304
P356
10.1212/01.WNL.0000065916.25128.25
P407
P577
2003-06-01T00:00:00Z